Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multi-Centre Placebo-Controlled Crossover Study Followed by an Open Label Post-Study Follow-up to Examine the Efficacy and Safety of Movicol in the Treatment of Chronic Constipation in Children

NCT00403819 is registered in ClinicalTrials.gov with Norgine as lead sponsor.

NCT NCT00403819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00403819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multi-Centre Placebo-Controlled Crossover Study Followed by an Open Label Post-Study Follow-up to Examine the Efficacy and Safety of Movicol in the Treatment of Chronic Constipation in Children
Lead sponsor
Norgine
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2002
Completion date
April 30, 2003
Enrollment
60
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chronic constipation